PDE7A-IN-1 (Compound 26) is an orally active PDE7A inhibitor with an IC50 value of 3.7 nM. By inhibiting sclerostin, PDE7A-IN-1 significantly enhances bone mineral density, making it suitable for studies on osteoporosis and related bone metabolic disorders.
Molecular Weight:
463.96
Formula:
C25H26ClN5O2
Target:
PDE
* VAT and and shipping costs not included. Errors and price changes excepted